Published in Calcif Tissue Int on July 05, 2013
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res (2015) 1.49
Sarcopenia: burden and challenges for public health. Arch Public Health (2014) 1.09
Clinical definition of sarcopenia. Clin Cases Miner Bone Metab (2014) 0.96
Determinants of Muscle and Bone Aging. J Cell Physiol (2015) 0.92
Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing (2015) 0.87
Identification of skeletal muscle mass depletion across age and BMI groups in health and disease--there is need for a unified definition. Int J Obes (Lond) (2014) 0.85
Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life. Osteoporos Int (2015) 0.83
Sarcopenia in daily practice: assessment and management. BMC Geriatr (2016) 0.81
Long-term impact of HIV wasting on physical function. AIDS (2016) 0.81
Bioelectrical phase angle and psoriasis: a novel association with psoriasis severity, quality of life and metabolic syndrome. J Transl Med (2016) 0.80
Associations between daily physical activity, handgrip strength, muscle mass, physical performance and quality of life in prefrail and frail community-dwelling older adults. Qual Life Res (2016) 0.80
The significance of body mass index in calculating the cut-off points for low muscle mass in the elderly: methodological issues. Biomed Res Int (2014) 0.79
Skeletal muscle homeostasis and plasticity in youth and ageing: impact of nutrition and exercise. Acta Physiol (Oxf) (2015) 0.79
Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle (2016) 0.78
Frailty and Constellations of Factors in Aging HIV-infected and Uninfected Women - The Women's Interagency HIV Study. J Frailty Aging (2016) 0.76
Age-related decline in muscle mass and muscle function in Flemish Caucasians: a 10-year follow-up. Age (Dordr) (2016) 0.76
Effects of whole body vibration exercises on bone mineral density of women with postmenopausal osteoporosis without medications: novel findings and literature review. J Musculoskelet Neuronal Interact (2016) 0.75
Physical activity and incidence of sarcopenia: the population-based AGES-Reykjavik Study. Age Ageing (2016) 0.75
Reference standards for lean mass measures using GE dual energy x-ray absorptiometry in Caucasian adults. PLoS One (2017) 0.75
English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing (2016) 0.75
The effects of antihypertensive medications on physical function. Prev Med Rep (2016) 0.75
Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. J Diabetes Metab Disord (2017) 0.75
Effectiveness of a multicomponent exercise program in the attenuation of frailty in long-term nursing home residents: study protocol for a randomized clinical controlled trial. BMC Geriatr (2017) 0.75
Dexamethasone and BCAA Failed to Modulate Muscle Mass and mTOR Signaling in GH-Deficient Rats. PLoS One (2015) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci (2001) 42.21
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes (2006) 26.32
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med (1995) 20.53
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing (2010) 17.45
Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci (2000) 15.54
The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care (2007) 13.29
Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc (2001) 11.09
Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol (1998) 10.23
Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res (2002) 9.99
The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2006) 7.38
Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA (2006) 6.93
Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54
Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci (2005) 6.42
A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health (1980) 6.29
Midlife hand grip strength as a predictor of old age disability. JAMA (1999) 6.23
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol (1985) (2003) 5.73
Cachexia: a new definition. Clin Nutr (2008) 5.49
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study. J Appl Physiol (1985) (2001) 5.35
Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ (2002) 4.92
Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol (2012) 4.87
A measure of quality of life in early old age: the theory, development and properties of a needs satisfaction model (CASP-19). Aging Ment Health (2003) 4.04
Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc (2003) 4.02
Validation of the Cumulative Illness Rating Scale in a geriatric residential population. J Am Geriatr Soc (1995) 3.92
The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies. J Am Geriatr Soc (2005) 3.73
Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care (2008) 3.54
Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr (2009) 3.44
A comparative review of generic quality-of-life instruments. Pharmacoeconomics (2000) 3.42
A brief clinical instrument to classify frailty in elderly people. Lancet (1999) 3.27
A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing (2011) 3.27
Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J Gerontol A Biol Sci Med Sci (2009) 3.14
A research and service oriented multilevel assessment instrument. J Gerontol (1982) 2.94
Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care (2007) 2.87
Sarcopenia =/= dynapenia. J Gerontol A Biol Sci Med Sci (2008) 2.82
Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci (2012) 2.82
Quality of life related to fear of falling and hip fracture in older women: a time trade off study. BMJ (2000) 2.79
Objective measures of physical capability and subsequent health: a systematic review. Age Ageing (2010) 2.78
Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res (2004) 2.76
Frailty, hospitalization, and progression of disability in a cohort of disabled older women. Am J Med (2005) 2.74
Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care (2009) 2.68
The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging (2008) 2.53
Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr (2004) 2.48
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Models, definitions, and criteria of frailty. Aging Clin Exp Res (2003) 2.42
Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol (2009) 2.39
Abandoning the language of "response shift": a plea for conceptual clarity in distinguishing scale recalibration from true changes in quality of life. Qual Life Res (2010) 2.36
Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res (2005) 2.26
Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments. BMC Med Res Methodol (2006) 2.23
Age-related changes in the structure and function of skeletal muscles. Clin Exp Pharmacol Physiol (2007) 2.22
Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporos Int (1999) 2.20
Development of the WHOQOL-old module. Qual Life Res (2005) 2.05
Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc (2009) 2.04
Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care (2005) 2.03
Sex differences in the risk of frailty for mortality independent of disability and chronic diseases. J Am Geriatr Soc (2005) 2.03
Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study. Clin Nutr (2012) 1.97
Functional outcomes for clinical trials in frail older persons: time to be moving. J Gerontol A Biol Sci Med Sci (2008) 1.83
Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing (2013) 1.79
Muscle fiber size and function in elderly humans: a longitudinal study. J Appl Physiol (1985) (2008) 1.76
Does admission grip strength predict length of stay in hospitalised older patients? Age Ageing (2006) 1.74
A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE). BMC Geriatr (2010) 1.71
Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr (2009) 1.68
Physical activity is related to quality of life in older adults. Health Qual Life Outcomes (2006) 1.63
Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int (2012) 1.58
Physical activity, disability, and quality of life in older adults. Phys Med Rehabil Clin N Am (2010) 1.58
Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing (2006) 1.56
Sarcopenia and frailty: a clinician's controversial point of view. Exp Gerontol (2008) 1.54
Conceptualizations of frailty in relation to older adults. J Adv Nurs (2003) 1.54
Absolute strength and loss of strength as predictors of mobility decline in older adults: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2011) 1.49
The mediating role of C-reactive protein and handgrip strength between obesity and walking limitation. J Am Geriatr Soc (2007) 1.47
Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics (2005) 1.44
Exercise as an intervention for frailty. Clin Geriatr Med (2011) 1.40
Patterns of comorbid inflammatory diseases in frail older women: the Women's Health and Aging Studies I and II. J Gerontol A Biol Sci Med Sci (2009) 1.34
The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. J Nutr Health Aging (2009) 1.30
The predictive validity of the Tilburg Frailty Indicator: disability, health care utilization, and quality of life in a population at risk. Gerontologist (2012) 1.30
Longitudinal body composition changes in old men and women: interrelationships with worsening disability. J Gerontol A Biol Sci Med Sci (2007) 1.29
Dimensions and correlates of quality of life according to frailty status: a cross-sectional study on community-dwelling older adults referred to an outpatient geriatric service in Italy. Health Qual Life Outcomes (2010) 1.29
Skeletal muscle protein metabolism in the elderly: Interventions to counteract the 'anabolic resistance' of ageing. Nutr Metab (Lond) (2011) 1.28
Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology (2007) 1.28
Measuring quality of life in women with osteoporosis. Osteoporosis Quality of Life Study Group. Osteoporos Int (1997) 1.28
Muscle endurance in elderly nursing home residents is related to fatigue perception, mobility, and circulating tumor necrosis factor-alpha, interleukin-6, and heat shock protein 70. J Am Geriatr Soc (2007) 1.27
A role for myokines in muscle-bone interactions. Exerc Sport Sci Rev (2011) 1.26
Lower plasma vitamin E levels are associated with the frailty syndrome: the InCHIANTI study. J Gerontol A Biol Sci Med Sci (2006) 1.24
The future of measuring patient-reported outcomes in rheumatology: Patient-Reported Outcomes Measurement Information System (PROMIS). Arthritis Care Res (Hoboken) (2011) 1.22
Frailty and health related quality of life in older Mexican Americans. Health Qual Life Outcomes (2009) 1.22
Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care (2012) 1.21
What does quality of life mean to older frail and non-frail community-dwelling adults in the Netherlands? Qual Life Res (2006) 1.20
Relevance of vitamin D in muscle health. Rev Endocr Metab Disord (2012) 1.19
Toward a common language of disablement. J Gerontol A Biol Sci Med Sci (2009) 1.18
Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST. Qual Life Res (2001) 1.17
Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging (2010) 1.17
Which measure of quality of life performs best in older age? A comparison of the OPQOL, CASP-19 and WHOQOL-OLD. J Epidemiol Community Health (2010) 1.15
Dietary implications on mechanisms of sarcopenia: roles of protein, amino acids and antioxidants. J Nutr Biochem (2009) 1.14
Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc (2012) 1.14
European innovation partnership on active and healthy ageing: triggers of setting the headline target of 2 additional healthy life years at birth at EU average by 2020. Arch Public Health (2012) 1.12
Sarcopenia in the elderly: diagnosis, physiopathology and treatment. Maturitas (2011) 1.10
Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL). J Bone Miner Res (1997) 1.08
How to get serious answers to the serious question: "How have you been?": subjective quality of life (QOL) as an individual experiential emergent construct. Bioethics (1999) 1.07
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing (2010) 17.45
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Gait speed and survival in older adults. JAMA (2011) 15.01
Effect of in utero and early-life conditions on adult health and disease. N Engl J Med (2008) 14.46
Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med (2007) 9.83
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med (2007) 7.60
Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am (2004) 7.59
The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2006) 7.38
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet (2009) 6.66
Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med (2014) 6.56
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med (2004) 6.55
Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47
Predictive value of BMD for hip and other fractures. J Bone Miner Res (2005) 6.46
Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med (2010) 6.13
Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci (2006) 6.08
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (2013) 5.93
Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N Engl J Med (2002) 5.83
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Osteoporosis. Lancet (2006) 5.40
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis (2012) 4.81
The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36
Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36
Using natural experiments to evaluate population health interventions: new Medical Research Council guidance. J Epidemiol Community Health (2012) 4.26
Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med (2010) 4.24
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15
Cohort profile: The Southampton Women's Survey. Int J Epidemiol (2005) 4.11
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc (2003) 4.02
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab (2008) 3.67
Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care (2008) 3.54
Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51
Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr (2009) 3.44
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr (2005) 3.40
Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database. Int J Epidemiol (2006) 3.36
Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab (2005) 3.36
Grip strength, body composition, and mortality. Int J Epidemiol (2006) 3.36
Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res (2010) 3.33
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet (2013) 3.31
A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing (2011) 3.27
Prevalence and impact of musculoskeletal disorders of the upper limb in the general population. Arthritis Rheum (2004) 3.24
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes (2011) 3.18
Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res (2002) 3.15
Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc (2009) 3.12
Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med (2006) 3.10
Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med (2003) 3.07
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care (2004) 3.02
Randomized, placebo-controlled trial of clodronate in patients with primary operable breast cancer. J Clin Oncol (2002) 3.01
Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc (2007) 2.94
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum (2006) 2.82
Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr (2008) 2.81
The lifestyle interventions and independence for elders (LIFE) pilot study: design and methods. Contemp Clin Trials (2005) 2.79
Objective measures of physical capability and subsequent health: a systematic review. Age Ageing (2010) 2.78
Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc (2003) 2.76
The cost-effectiveness of alendronate in the management of osteoporosis. Bone (2007) 2.75
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73
Intelligence in childhood and chronic widespread pain in middle age: the National Child Development Survey. Pain (2012) 2.71
Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr (2003) 2.70
Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab (2007) 2.68
Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. Am J Clin Nutr (2005) 2.67
The relationship between leg power and physical performance in mobility-limited older people. J Am Geriatr Soc (2002) 2.65
Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study. J Gerontol A Biol Sci Med Sci (2004) 2.64
Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop (2011) 2.60
Validation of the Late-Life Function and Disability Instrument. J Am Geriatr Soc (2004) 2.56
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum (2009) 2.55
Women's compliance with nutrition and lifestyle recommendations before pregnancy: general population cohort study. BMJ (2009) 2.54
Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis. J Bone Miner Res (2011) 2.53
Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study. J Bone Miner Res (2003) 2.47
Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart (2010) 2.42
Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology (2005) 2.39
Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res (2003) 2.38
Vitamin D: some perspective please. BMJ (2012) 2.35